Literature DB >> 20353497

Intestinal B cell-activating factor: an indicator of non-IgE-mediated hypersensitivity reactions to food?

G Arslan Lied1, K Lillestøl, J Valeur, A Berstad.   

Abstract

BACKGROUND: Medically confirmed hypersensitivity reactions to food are usually IgE-mediated. Non-IgE-mediated reactions are not only seldom recognized but also more difficult to diagnose. AIM: To examine B cell-activating factor (BAFF) in serum and gut lavage fluid of patients with self-reported food hypersensitivity, and to study its relationship to atopic disease.
METHODS: Gut lavage fluid was obtained from 60 and serum from another 17 patients with self-reported food hypersensitivity. Twenty healthy volunteers served as controls, gut lavage fluid was obtained in all, serum from 11 of 20. The patients were divided into atopic and non-atopic subgroups. BAFF was measured by ELISA in both serum and gut lavage fluid.
RESULTS: B cell-activating factor levels in serum and gut lavage fluid were significantly higher in patients than in controls (P < 0.03 and P < 0.002 respectively). Non-atopic patients had significantly higher levels of BAFF in serum than both atopic patients (P < 0.05) and controls (P < 0.05). There was no significant correlation between serum levels of BAFF and IgE.
CONCLUSIONS: The results suggest that BAFF might be a new mediating mechanism in food hypersensitivity reactions. Significantly higher levels in non-atopic compared with atopic patients, and no correlation between BAFF and IgE, suggest that BAFF might be involved particularly in non-IgE-mediated reactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20353497     DOI: 10.1111/j.1365-2036.2010.04314.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

1.  Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity.

Authors:  Anna Ghirardello; Salvatore Gizzo; Marco Noventa; Michela Quaranta; Amerigo Vitagliano; Nicoletta Gallo; Giorgia Pantano; Marianna Beggio; Chiara Cosma; Michele Gangemi; Mario Plebani; Andrea Doria
Journal:  J Assist Reprod Genet       Date:  2015-10-14       Impact factor: 3.412

Review 2.  Clinical spectrum of food allergies: a comprehensive review.

Authors:  Marco H-K Ho; Wilfred H-S Wong; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

Review 3.  B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

Authors:  Mathieu Uzzan; Jean-Frederic Colombel; Andrea Cerutti; Xavier Treton; Saurabh Mehandru
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

Review 4.  Indication of immune activation in patients with perceived food hypersensitivity.

Authors:  Gülen Arslan Lied
Journal:  Dig Dis Sci       Date:  2013-11-02       Impact factor: 3.199

5.  Dendritic cell populations in patients with self-reported food hypersensitivity.

Authors:  Gülen A Lied; Petra Vogelsang; Arnold Berstad; Silke Appel
Journal:  Int J Gen Med       Date:  2011-05-15

6.  The strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF).

Authors:  Adriana Bornacelly; Dilia Mercado; Nathalie Acevedo; Luis Caraballo
Journal:  BMC Immunol       Date:  2014-06-07       Impact factor: 3.615

7.  No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection.

Authors:  Kurt Hanevik; Christina Saghaug; Maren Aaland; Kristine Morch; Nina Langeland
Journal:  JGH Open       Date:  2022-03-14

Review 8.  Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease.

Authors:  Marko Kumric; Piero Marin Zivkovic; Tina Ticinovic Kurir; Josip Vrdoljak; Marino Vilovic; Dinko Martinovic; Andre Bratanic; Ivan Kresimir Lizatovic; Josko Bozic
Journal:  Diagnostics (Basel)       Date:  2021-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.